TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
REPL

Replimune Group Inc

Healthcare · Biotechnology

12.90$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Replimune Group Inc (REPL) with date, type and a link to the original document.

Filings REPL
Date Type Filing Original
09/16/2026 Current report (8-K) Replimune Group, Inc. (REPL): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View report ↗
08/14/2026 Current report (8-K) Replimune Group, Inc. (REPL): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗
08/10/2026 Current report (8-K) Replimune Group, Inc. (REPL): Other Events; Financial Statements and Exhibits View report ↗
08/10/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
08/10/2026 Capital measure Form 424B5 filed with the SEC View document ↗
08/07/2026 Current report (8-K) Replimune Group, Inc. (REPL): Other Events; Financial Statements and Exhibits View report ↗
08/07/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
07/31/2026 Current report (8-K) Replimune Group, Inc. (REPL): Other Events; Financial Statements and Exhibits View report ↗
07/30/2026 Current report (8-K) Replimune Group, Inc. (REPL): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?